Shares of Basf Se (OTCMKTS:BASFY) have earned an average rating of “Hold” from the ten ratings firms that are covering the stock. Two investment analysts have rated the stock with a sell recommendation, three have given a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $97.00.

BASFY has been the topic of a number of recent analyst reports. Zacks Investment Research raised shares of Basf Se from a “sell” rating to a “hold” rating in a research report on Friday, September 2nd. DZ Bank AG reaffirmed a “buy” rating on shares of Basf Se in a research report on Friday, October 28th. Citigroup Inc. reaffirmed a “buy” rating on shares of Basf Se in a research report on Monday, September 26th. Finally, Credit Suisse Group AG reaffirmed a “sell” rating on shares of Basf Se in a research report on Sunday, October 16th.

Shares of Basf Se (OTCMKTS:BASFY) opened at 84.71 on Monday. The stock has a 50 day moving average of $0.00 and a 200-day moving average of $0.00. Basf Se has a 12-month low of $63.52 and a 12-month high of $89.10.

COPYRIGHT VIOLATION WARNING: “Brokerages Set Basf Se (BASFY) PT at $97.00” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at

Basf Se Company Profile

BASF SE is a chemical company. The Company operates through five segments: Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions, and Oil & Gas. The Chemicals segment consists of the Petrochemicals, Monomers and Intermediates divisions. Its portfolio ranges from solvents, plasticizers and high-volume monomers to glues and electronic chemicals, as well as raw materials for detergents, plastics, textile fibers, paints and coatings, crop protection and medicines.

Receive News & Stock Ratings for Basf Se Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basf Se and related stocks with our FREE daily email newsletter.